VS

Venkatesh Sowarnapuri Pandhadu

Active Director Designated Partner DIN 09399085
DIN 09399085 First appointment Nov 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkatesh Sowarnapuri Pandhadu

Data last updated:

Venkatesh Sowarnapuri Pandhadu is a Designated Partner at Biovistas Medicaments Llp (since 2021). The company operates in Chemicals.

DIN 09399085
Primary Designation Designated Partner
Industry Chemicals
First Appointment 15 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Nov 20212021Active

Board colleagues of Venkatesh Sowarnapuri Pandhadu

NameDINCompanyDesignation
Kurathalwar Harikrishnan09399084Biovistas Medicaments LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Biovistas Medicaments Llp
Premium access

Shareholding and investment profile for Venkatesh Sowarnapuri Pandhadu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkatesh Sowarnapuri Pandhadu

Venkatesh Sowarnapuri Pandhadu currently holds 1 directorship: Biovistas Medicaments Llp (Designated Partner, since 15 Nov 2021).

Venkatesh Sowarnapuri Pandhadu was first appointed on 15 Nov 2021 as Designated Partner at Biovistas Medicaments Llp.

The current boards of Venkatesh Sowarnapuri Pandhadu's companies include Kurathalwar Harikrishnan (Biovistas Medicaments Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available